Top news of the week: 11.03.2021.
Healthcare
Listen: Peace among the pharma giants, the next phase of the pandemic, & a little Covid-19 optimism
This episode, we discuss Merck's decision to help J&J manufacture vaccine doses and whether it'll be a turning point for the drug industry.
Clinical Catch-Up: March 1-5
It was another busy week for clinical trial announcements. Here’s a look.
2020 NIH Antiviral Summit Report
National Institutes of Health Summit Report Authors Annaliesa Anderson, Pfzer James M. Anderson, Offce of the Director, NIH Kara Carter, Evotec* Tomas Cihlar, Gilead Sciences …
10 Mar Complix Signs Global Drug Discovery and Development Agreement with I-Mab to Develop Cell Penetrating Alphabodies against Two Intracellular Immuno-oncology Targets
Complix retains joint development and commercialization rights outside Greater China Complix to receive upfront fees and research funding as well as potential milestone and …
Mental Health: A New Frontier for Biotech
Mental health problems were mounting heading into this pandemic. Now, the challenges are bigger and coming in waves. There’s the grief. Think about all the family and friends of the more ...
Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection center
Point-of-care (POC) tests are in high demand in order to facilitate rapid care decisions for patients suspected of SARS-CoV-2. We conducted a clinical validation study of the Cue Health POC ...
Amgen Offers $1.9 Billion to Acquire Five Prime Therapeutics
Five Prime Therapeutics shares traded 78% higher after the company reported it entered into a definitive agreement to be acquired by biotech giant Amgen for $38 per share in cash.
How repurposing a drug in a COVID-19 trial could benefit people with cancer
We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer.